menu
    • menu

    Company profile for Protagonist Therapeutics

    NEW Drugs in Dev: 9
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. We have successfully utilized the platform to date to identify oral, GI-restricted peptides (PTG-100 and PTG-200) for inflammatory bowel diseases (IBD) ...
    a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. We have successfully utilized the platform to date to identify oral, GI-restricted peptides (PTG-100 and PTG-200) for inflammatory bowel diseases (IBD) and injectable peptides (PTG-300) for rare blood disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Protagonist TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7707 Gateway Boulevard, Suite 140 Newark, CA 94560-1160 USA
    Telephone
    Telephone
    +1 510 474 0170
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.protagonist-inc.com/home-page/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/protagonist-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Protagonist to Present Phase 3 VERIFY & Long-Term Rusfertide Data
    Protagonist to Present Phase 3 VERIFY & Long-Term Rusfertide Data

    01 Jun 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/protagonist-therapeutics-to-present-phase-3-verify-and-long-term-rusf-1172096

    ACCESSWIRE
    01 Jun 2026
    Share Share
    Protagonist Therapeutics to Present at Two Conferences
    Protagonist Therapeutics to Present at Two Conferences

    28 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-28/protagonist-therapeutics-to-participate-in-two-investment-bank-conferences-in-june-2026

    PHARMIWEB
    28 May 2026
    Share Share
    Protagonist Unveils Q1 2026 Financials And Corporate Update
    Protagonist Unveils Q1 2026 Financials And Corporate Update

    05 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-05/protagonist-reports-first-quarter-2026-financial-results-and-provides-corporate-update

    PHARMIWEB
    05 May 2026
    Share Share
    Protagonist Exercises U.S. Opt-Out Right for Rusfertide
    Protagonist Exercises U.S. Opt-Out Right for Rusfertide

    28 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-28/protagonist-exercises-rusfertide-us-opt-out-right-under-takeda-collaboration

    PHARMIWEB
    28 Apr 2026
    Share Share
    Protagonist Therapeutics Reports Granting Of Inducement Awards
    Protagonist Therapeutics Reports Granting Of Inducement Awards

    16 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-16/protagonist-therapeutics-reports-granting-of-inducement-awards

    PHARMIWEB
    16 Apr 2026
    Share Share
    J&J Charts Speedy Launch Of New Psoriasis Pill Icotyde
    J&J Charts Speedy Launch Of New Psoriasis Pill Icotyde

    14 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jj-chasing-100b-year-shapes-immunology-dual-powerhouse-tremfya-and-newly-launched-icotyde

    FIERCE PHARMA
    14 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search